Northern Trust Corp Regenxbio Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Regenxbio Inc. stock. As of the latest transaction made, Northern Trust Corp holds 487,987 shares of RGNX stock, worth $4.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
487,987
Previous 432,250 12.89%
Holding current value
$4.7 Million
Previous $5.06 Million 1.21%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$10.49 - $14.39 $584,681 - $802,055
55,737 Added 12.89%
487,987 $5.12 Million
Q2 2024

Aug 14, 2024
BUY
$11.51 - $21.53 $5,352 - $10,011
465 Added 0.11%
432,250 $5.06 Million
Q1 2024

May 14, 2024
SELL
$12.17 - $24.61 $182,403 - $368,854
-14,988 Reduced 3.35%
431,785 $9.1 Million
Q4 2023

Feb 13, 2024
BUY
$12.89 - $20.82 $215,752 - $348,485
16,738 Added 3.89%
446,773 $8.02 Million
Q3 2023

Nov 13, 2023
BUY
$16.46 - $19.99 $252,759 - $306,966
15,356 Added 3.7%
430,035 $7.08 Million
Q2 2023

Aug 11, 2023
BUY
$17.23 - $21.71 $73,761 - $92,940
4,281 Added 1.04%
414,679 $8.29 Million
Q1 2023

May 15, 2023
SELL
$18.08 - $24.55 $335,402 - $455,427
-18,551 Reduced 4.32%
410,398 $7.76 Million
Q4 2022

Feb 13, 2023
SELL
$20.4 - $24.73 $1.21 Million - $1.46 Million
-59,225 Reduced 12.13%
428,949 $9.73 Million
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $1.45 Million - $2.28 Million
65,060 Added 15.38%
488,174 $12.9 Million
Q2 2022

Aug 12, 2022
BUY
$19.35 - $35.04 $156,715 - $283,788
8,099 Added 1.95%
423,114 $10.5 Million
Q1 2022

May 13, 2022
SELL
$24.62 - $34.31 $280,347 - $390,687
-11,387 Reduced 2.67%
415,015 $13.8 Million
Q4 2021

Feb 08, 2022
SELL
$30.19 - $40.28 $1.76 Million - $2.35 Million
-58,316 Reduced 12.03%
426,402 $13.9 Million
Q3 2021

Nov 15, 2021
BUY
$29.09 - $45.68 $187,863 - $295,001
6,458 Added 1.35%
484,718 $20.3 Million
Q2 2021

Aug 13, 2021
BUY
$32.46 - $40.48 $1.28 Million - $1.6 Million
39,515 Added 9.01%
478,260 $18.6 Million
Q1 2021

May 12, 2021
BUY
$33.61 - $49.95 $1.61 Million - $2.4 Million
48,013 Added 12.29%
438,745 $15 Million
Q4 2020

Feb 11, 2021
SELL
$26.52 - $49.35 $217,676 - $405,064
-8,208 Reduced 2.06%
390,732 $17.7 Million
Q3 2020

Nov 16, 2020
SELL
$27.01 - $40.26 $819,861 - $1.22 Million
-30,354 Reduced 7.07%
398,940 $11 Million
Q2 2020

Aug 14, 2020
BUY
$27.75 - $43.44 $525,279 - $822,275
18,929 Added 4.61%
429,294 $15.8 Million
Q1 2020

May 14, 2020
BUY
$21.5 - $54.2 $69,208 - $174,469
3,219 Added 0.79%
410,365 $13.3 Million
Q4 2019

Feb 14, 2020
SELL
$34.54 - $44.87 $796,803 - $1.04 Million
-23,069 Reduced 5.36%
407,146 $16.7 Million
Q3 2019

Nov 13, 2019
BUY
$31.84 - $50.88 $130,862 - $209,116
4,110 Added 0.96%
430,215 $15.3 Million
Q2 2019

Aug 13, 2019
BUY
$42.0 - $59.29 $332,724 - $469,695
7,922 Added 1.89%
426,105 $21.9 Million
Q1 2019

May 13, 2019
BUY
$40.82 - $62.45 $212,059 - $324,427
5,195 Added 1.26%
418,183 $24 Million
Q4 2018

Feb 12, 2019
BUY
$39.11 - $75.15 $121,201 - $232,889
3,099 Added 0.76%
412,988 $17.3 Million
Q3 2018

Nov 14, 2018
BUY
$65.0 - $82.15 $3.31 Million - $4.18 Million
50,849 Added 14.16%
409,889 $30.9 Million
Q2 2018

Sep 18, 2018
SELL
$27.2 - $74.35 $47,110 - $128,774
-1,732 Reduced 0.48%
359,040 $25.8 Million
Q2 2018

Aug 14, 2018
BUY
$27.2 - $74.35 $1.76 Million - $4.8 Million
64,581 Added 21.8%
360,772 $25.9 Million
Q1 2018

May 09, 2018
BUY
$24.05 - $37.5 $1,948 - $3,037
81 Added 0.03%
296,191 $8.84 Million
Q4 2017

Feb 14, 2018
SELL
$26.0 - $34.6 $501,670 - $667,607
-19,295 Reduced 6.12%
296,110 $9.85 Million
Q3 2017

Nov 13, 2017
BUY
$18.0 - $32.95 $5.68 Million - $10.4 Million
315,405
315,405 $10.4 Million

Others Institutions Holding RGNX

# of Institutions
197
Shares Held
43.2M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $416M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email